Health Care Technology
Company Overview of Rennova Health, Inc.
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers in the United States. It offers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices. The company provides toxicology, clinical pharmacogenetics, and esoteric testing services; develops Web-based system to place lab orders, track samples, and view test reports in real time; Web-enabled laboratory information management solutions; Medical Mime, which offers an electronic health record for substance abuse and behavioral health p...
400 South Australian Avenue
West Palm Beach, FL 33401
Founded in 2005
Key Executives for Rennova Health, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer
Total Annual Compensation: $80.8K
Compensation as of Fiscal Year 2015.
Rennova Health, Inc. Key Developments
Rennova Health Enters into Preferred Provider Agreement with Three Rivers Providers Network
Jun 28 16
Rennova Health, Inc. announced that it has entered into a preferred provider network agreement with Three Rivers Provider Network, effective May 1, 2016. Under the agreement, TRPN’s more than 200 million members serviced at 1.5 million healthcare locations across the U.S. will now have access to Rennova’s high-complexity diagnostic testing laboratories.
Rennova Health, Inc. Complies With Nasdaq Rule 5550(b)
Jun 9 16
On April 26, 2016, Rennova Health, Inc. was notified by Nasdaq that the stockholders’ equity balance reported on the company’s Form 10-K for the year ended December 31, 2015 fell below the $2,500,000 minimum requirement for continued listing under the Nasdaq Capital Market’s Listing Rule 5550(b)(1), and that the company had until June 10, 2016 to prepare and submit a plan to Nasdaq outlining how the company intended to regain compliance. As a result of discussions between the company and Nasdaq, it was determined that the company currently complies with Nasdaq’s Continued Listing Standards due to the fact that the company had net income from continuing operations in excess of $500,000 in two of the three most recently completed fiscal years, as set out in the Nasdaq Capital Market’s Listing Rule 5550(b)(3). As a result, on June 8, 2016, Nasdaq notified the company that it complies with Rule 5550(b) and that the matter is now closed.
Rennova Health, Inc. Presents at 6th Annual LD Micro Invitational Conference, Jun-07-2016 02:00 PM
May 31 16
Rennova Health, Inc. Presents at 6th Annual LD Micro Invitational Conference, Jun-07-2016 02:00 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 20, 2016
January 6, 2016